U.S. Pharma Stock News

NYSE:AMCR
NYSE:AMCRPackaging

Is Amcor (AMCR) Now Attractively Priced After Recent Share Price Pullback

Investors may be wondering whether Amcor's current share price reflects its true worth, or if the market is missing something important about this packaging company. Over the last week the stock is up 4.5%, although the return over 30 days is an 8.0% decline and the 1-year return sits at a 5.4% loss, which may have shifted how some investors view its risk and potential. These mixed returns have kept attention on how the market is reacting to Amcor and how sentiment can change quickly when...
NYSE:WK
NYSE:WKSoftware

Is Workiva (WK) Starting To Look Attractive After Steep Share Price Declines?

Wondering whether Workiva is starting to look attractively priced or still too expensive at around US$59.77 per share? This article breaks down what that price could imply about value. The stock is up 1.8% over the last 7 days, while the 1 year return sits at a 9.4% loss and the year to date return is a 28.0% loss, with a 30 day return of a 7.9% loss. Recent coverage around Workiva has focused on how the share price performance contrasts with its longer term track record, which includes a...
NYSE:OXY
NYSE:OXYOil and Gas

Is Occidental Petroleum (OXY) Pricing In Too Much Optimism After Its Strong 1 Year Rally?

If you are wondering whether Occidental Petroleum at around US$62.96 offers value or is primarily driven by sentiment, this article walks through the numbers so you can assess the price tag with more confidence. The stock recently saw a 5.0% decline over the last 7 days, alongside a 16.2% gain over 30 days and returns of 48.6% year to date and 66.0% over 1 year. Recent attention on Occidental Petroleum has focused on its role in the US energy sector and how investors interpret its exposure...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Is Astrana Health (ASTH) Offering Value After Recent Share Price Rebound?

If you are wondering whether Astrana Health at around US$26 is offering good value or fresh risk, it helps to compare the share price with what the underlying business might be worth. The stock has recently moved, with returns of 6.8% over the last 7 days and 4.4% over the past month, while the 1 year return sits at an 11.2% decline and the 3 year return at a 33.2% decline. This can change how the market views both its potential and its risks. These moves come as investors continue to assess...
NYSE:RDN
NYSE:RDNDiversified Financial

Radian Group Inigo Deal Shifts Earnings Mix Beyond US Housing Cycle

Radian Group (NYSE:RDN) has agreed to acquire specialty insurer and reinsurer Inigo, expanding beyond its core mortgage insurance business. The deal adds specialty P&C and reinsurance exposure to Radian's portfolio, reshaping the company's overall business mix. This transaction marks a meaningful shift in Radian's long term risk profile and revenue sources away from exclusive reliance on the US housing market. For investors watching Radian Group at a share price of $33.97, this move arrives...
NYSE:LBRT
NYSE:LBRTEnergy Services

Has Liberty Energy (LBRT) Run Too Far After A 170% One Year Share Price Surge

This article explores whether Liberty Energy's share price still reflects good value, or if the easier gains may already have occurred, by considering what the current price might be implying about the company. Liberty Energy closed at US$27.67, with a 4.1% decline over the last 7 days, a 3.2% gain over 30 days, a 46.6% return year to date, and a 169.7% return over the past year. Recent coverage has focused on Liberty Energy as part of broader discussions around US energy services companies...
NYSE:WS
NYSE:WSMetals and Mining

Assessing Worthington Steel (WS) Valuation After Q3 Earnings Update And Dividend Reaffirmation

Worthington Steel (WS) is back in focus after reporting third quarter results that showed higher sales but lower quarterly net income compared with a year earlier, along with higher nine-month earnings and a reaffirmed quarterly dividend. See our latest analysis for Worthington Steel. The latest results and dividend decision come after a mixed price pattern, with a 5.05% 7 day share price return, a 19.61% 30 day share price decline, and a 31.76% 1 year total shareholder return, suggesting...
NYSE:MDT
NYSE:MDTMedical Equipment

If You Believe In AI Healthcare Then These Three Stocks Could Shape Your Next Cycle

AI is starting to reshape how healthcare is delivered, from spotting disease earlier to tailoring treatments and cutting wasted time in hospitals, just as energy driven inflation and higher yields keep pressure on costs worldwide. For investors, that mix of structural healthcare demand and AI driven efficiency tools offers exposure to a theme that is less tied to short term swings in consumer spending or manufacturing cycles. This article walks through 3 stocks from our Transformative AI...
NYSE:AYI
NYSE:AYIElectrical

A Look At Acuity Brands (AYI) Valuation After Mixed Q2 2026 Earnings And Segment Trends

Acuity (AYI) is back in focus after its second quarter 2026 earnings, where adjusted earnings per share came in ahead of expectations while revenue lagged forecasts, highlighting contrasting trends across its Lighting and Intelligent Spaces businesses. See our latest analysis for Acuity. The share price reaction has been mixed, with a 1 day share price return of 1.06% after earnings but a 90 day share price return representing a 28.55% decline. However, the 3 year total shareholder return of...
NYSE:OLN
NYSE:OLNChemicals

Will Wells Fargo’s Margin-Focused Upgrade Shift Olin’s (OLN) Cost Advantage and Pricing Power Narrative?

Olin Corporation recently received an upgrade from Wells Fargo, with the firm citing expectations of stronger margins in its electrochemical operations supported by higher caustic soda prices and stable North American natural gas costs. This shift in analyst view highlights how Olin’s earnings outlook is increasingly being tied to both its cost position and evolving global chemical pricing shaped by geopolitical tensions. We’ll now examine how this margin-focused upgrade from Wells Fargo...
NYSE:PBH
NYSE:PBHPharmaceuticals

Why Prestige Consumer Healthcare (PBH) Is Down 5.8% After Heightened Regulatory Scrutiny On Its OTC Portfolio

In early April 2026, Prestige Consumer Healthcare faced pressure after regulatory scrutiny, including FTC concerns over industry consolidation and a federal healthcare fraud crackdown, weighed on sentiment around its over-the-counter product portfolio. Beyond the immediate regulatory overhang, the episode highlights how sector-wide oversight can quickly reshape market perceptions of risk around even established healthcare brands. Against this backdrop of intensified regulatory attention,...
NasdaqGS:HCSG
NasdaqGS:HCSGCommercial Services

A Look At Healthcare Services Group (HCSG) Valuation After Strong 1 Year Return And Recent Share Price Softness

Healthcare Services Group (HCSG) has been drawing attention after a strong 1 year total return of 85.35%, in contrast with recent share price softness over the past month and past 3 months. See our latest analysis for Healthcare Services Group. Recent trading has cooled after that strong 1 year total shareholder return of 85.35%. The 30 day share price return of an 11.14% decline points to fading near term momentum, even as the longer term total shareholder return profile remains positive...
NYSE:GBTG
NYSE:GBTGHospitality

A Look At Global Business Travel Group (GBTG) Valuation As Options Volatility Rises And UBS Reaffirms Rating

Global Business Travel Group (GBTG) is back on investor radar after options activity showed elevated implied volatility in certain call contracts. This coincides with UBS reaffirming its rating while trimming expectations and the company maintaining its 2026 guidance. See our latest analysis for Global Business Travel Group. At a share price of US$5.56, Global Business Travel Group has seen short term momentum soften, with a 7 day share price return of 2.96% set against a 90 day share price...
NasdaqGS:MYGN
NasdaqGS:MYGNBiotechs

Myriad Genetics And 2 Other Penny Stocks To Watch Closely

The United States market has shown robust growth, rising 3.5% over the last week and 31% over the past year, with earnings expected to increase by 16% annually in the coming years. In such a thriving market, identifying stocks with strong financials becomes crucial for investors seeking both affordability and growth potential. Although often considered a term from bygone eras, penny stocks continue to offer intriguing opportunities within smaller or newer companies that might surprise...
NasdaqGM:PDYN
NasdaqGM:PDYNMachinery

Undiscovered Gems In The US Market For April 2026

The United States market has shown impressive strength, rising 3.5% over the last week and climbing 31% over the past year, with earnings projected to grow by 16% annually. In such a robust environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer intriguing opportunities for investors seeking to diversify their portfolios.
NYSE:CPA
NYSE:CPAAirlines

Three Dividend Stocks Worth Considering

The market in the United States has shown a notable uptick, rising 3.5% over the last week and achieving a 31% increase over the past year, with earnings projected to grow by 16% annually. In such an environment, dividend stocks that offer consistent payouts and potential for growth can be appealing options for investors seeking to benefit from both income and capital appreciation.
NasdaqGS:JOYY
NasdaqGS:JOYYInteractive Media and Services

The Bull Case For JOYY (JOYY) Could Change Following BIGO Ads Expansion And New Segment Reporting

In its recent earnings call, JOYY highlighted accelerating ad-tech momentum, improving non-GAAP profitability, strong cash generation, and a sizeable net cash balance, while announcing a shift to three reporting segments starting Q1 2026. A key highlight was the rapid expansion of BIGO Ads’ third-party Audience Network, which is emerging as a central growth engine within JOYY’s evolving business mix. Next, we’ll examine how JOYY’s move to three reporting segments and spotlight on BIGO Ads...
NYSE:FCF
NYSE:FCFBanks

Did FCF’s Stronger‑Than‑Expected Revenue and Margin Expansion Just Shift First Commonwealth Financial’s (FCF) Investment Narrative?

In the past quarter, First Commonwealth Financial reported a 14.2% year-on-year revenue increase, surpassing analyst expectations while management pointed to healthy loan and deposit growth, wider net interest margin, and steady capital levels despite ongoing pressures on regional banks. This combination of outperformance and resilience against fintech competition and rising regulatory costs highlights how the bank’s core franchise is holding up under sector stress. With that backdrop, we’ll...
NYSE:TR
NYSE:TRFood

Will Cocoa Tariff Relief and Pricing Power Change Tootsie Roll Industries' (TR) Competitive Narrative?

Candy makers, including Tootsie Roll Industries, have recently benefited from sector-wide momentum as seasonal demand and pricing power helped offset higher input costs, while the rescinding of cocoa tariffs is expected to ease cost pressures in 2026. For Tootsie Roll, this combination of niche brand appeal and potentially lower cocoa-related expenses adds a fresh dimension to how investors may assess its competitive position. We’ll now examine how easing cocoa tariffs could influence...
NYSE:DNOW
NYSE:DNOWTrade Distributors

Should Rosen’s Securities Probe Into Disclosures Require Action From DNOW (DNOW) Investors?

Rosen Law Firm recently announced it is investigating potential securities claims against DNOW Inc., focusing on whether the company issued materially misleading business information to investors. This kind of legal scrutiny can raise questions about the reliability of DNOW’s prior disclosures, which matter for investors assessing its business quality and governance. With a securities law firm now probing DNOW’s disclosures, we’ll explore how this added litigation risk affects the company’s...
NYSE:UDR
NYSE:UDRResidential REITs

What UDR (UDR)'s Dividend Hike And Earnings Beat Mean For Shareholders

In recent days, UDR, Inc. reported strong Q4 2025 earnings, expanded a joint venture, and approved a 1.2% increase in its quarterly dividend, signaling continued commitment to shareholder payouts. Yet this positive operational update coincided with analysts trimming growth expectations while hedge funds increased their positions, highlighting a tension between cautious forecasts and renewed institutional interest. Next, we’ll explore how this combination of stronger earnings and a higher...